Langasog, Rudy S.

HRN: 23-51-55  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2023
CEFTRIAXONE 1G (VIAL)
08/07/2023
08/14/2023
IV
2 Grams
OD
PTB; CAP MR
Checking Final Appropriateness 
08/07/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/07/2023
08/07/2023
IV
4.5
Now
CAP MR
Checking Final Appropriateness 
08/07/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/08/2023
08/13/2023
IV
2.25gm
Q12H
CAP MR
08/09/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/09/2023
08/15/2023
IV
2.25gm
Q8
Acute Pyelonephritis
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: